Clinical Edge Journal Scan

Atopic Dermatitis Associated With Cognitive Impairment Symptoms in Children


 

Key clinical point: Atopic dermatitis (AD) is associated with a higher likelihood of cognitive impairment symptoms involving difficulties in learning or memory, especially in children with neurodevelopmental comorbidities, such as attention-deficit/hyperactivity disorder (ADHD) or learning disability.

Major finding: A significantly greater number of children with vs without AD experienced difficulties with learning (10.8% vs 5.9%) and memory (11.1% vs 5.8%; both P < .001). However, this association was observed only in children with neurodevelopmental disorders (adjusted odds ratio 2.26; 95% CI 1.43-3.57) including ADHD or learning disabilities.

Study details: This cross-sectional study analyzed the data of 7957 children, representing a weighted total of 69,732,807 children without intellectual disabilities from the 2021 US National Health Interview Survey who did (n = 9,223,013) or did not (n = 60,509,794) have AD. The survey randomly selects 1 child per surveyed household for whom a parent or adult caregiver provides information.

Disclosures: This study was supported by a grant to Joy Wan from the US National Institutes of Health. Joy Wan also declared receiving a grant and personal fees from various pharmaceutical companies. The other authors declared no conflicts of interest.

Source: Ma EZ, Chang HR, Radtke S, Wan J. Symptoms of cognitive impairment among children with atopic dermatitis. JAMA Dermatol. 2024 (Mar 6). doi: 10.1001/jamadermatol.2024.0015 Source

Recommended Reading

Dupilumab Efficacy in Atopic Dermatitis Is Not Influenced by Pathogenic Filaggrin Variants
MDedge Dermatology
Prevalence of Risk Factors Impacting Oral Janus Kinase Inhibitor Treatment in Atopic Dermatitis
MDedge Dermatology
Pretreatment Lab Testing for Chronic Skin Diseases Diverges From Guidelines
MDedge Dermatology
Company Announces Regulatory Filing for Nemolizumab for Two Indications
MDedge Dermatology
What Skin Manifestations Are Associated With Pediatric IBD?
MDedge Dermatology
Commentary: Medication Timing and Other Dupilumab Concerns, March 2024
MDedge Dermatology
Climate Change and AD: New Review Shows Negative Impacts and Unknowns
MDedge Dermatology
Omalizumab for Food Allergies: What PCPs Should Know
MDedge Dermatology
Is Atopic Dermatitis Linked to Cognitive Impairment Symptoms in Children?
MDedge Dermatology
Sublingual Immunotherapy Safe, Effective for Older Kids
MDedge Dermatology